免疫系统
趋化因子
氧化应激
串扰
CXCL2型
炎症
活性氧
免疫学
巨噬细胞
癌症研究
细胞生物学
生物
先天免疫系统
趋化因子受体
炎症性肠病
化学
免疫
肿瘤坏死因子α
氧化磷酸化
肿瘤微环境
结肠炎
促炎细胞因子
趋化性
肠道通透性
CXCL1型
超氧化物
作者
Qi Sun,Wanling Liu,Sijie Li,Xiwen Chen,Hanjie Zhang,Dongze Mo,Pinwen Zhou,Xiaomiao Cui,Di Huang,Bing Xia,Jingjing Zhang,Xinying Wang,Xiaoyu Wang,Hui Wei
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-11-10
标识
DOI:10.1021/acsnano.6c16014
摘要
Abstract Colitis-associated colorectal cancer (CAC) arises from chronic inflammatory niches characterized by persistent oxidative stress and dysregulated immune cell recruitment. Current anti-inflammatory therapies provide only transient symptom relief and fail to prevent malignant progression due to their inability to simultaneously mitigate oxidative injury and immune chemotaxis. Our analysis of clinical samples revealed markedly elevated C-X-C motif chemokine ligand 2 (CXCL2) in intestinal tissues from patients with inflammatory bowel disease and CAC, implicating the CXCL2-CXCR2 (C-X-C motif chemokine receptor 2) axis in driving excessive neutrophil and macrophage infiltration and fostering tumorigenesis. Herein, we report a biomimetic nanozyme (PB@ECM) that reprograms inflammatory immune niches to intercept CAC progression. PB@ECM integrates a Prussian blue nanozyme core with genetically engineered macrophage membranes, enabling concurrent scavenging of reactive oxygen species through superoxide dismutase- and catalase-like activities and sequestration of CXCL2 via membrane-displayed CXCR2 receptors. In murine models of colitis and CAC, PB@ECM significantly alleviated intestinal inflammation, suppressed neutrophil and macrophage infiltration, and effectively inhibited colitis-carcinoma transition. Notably, treatment with PB@ECM significantly prolonged survival compared with other groups. By disrupting the pathological crosstalk between oxidative stress and immune chemotaxis, this work establishes a biomimetic nanozyme strategy for preventing inflammation-driven carcinogenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI